Orchard Therapeutics PLC Sponsored ADR Net Income 2019-2023 | ORTX
Orchard Therapeutics PLC Sponsored ADR net income from 2019 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Orchard Therapeutics PLC Sponsored ADR Annual Net Income (Millions of US $) |
|
|---|---|
| 2022 | $-151 |
| 2021 | $-145 |
| 2020 | $-152 |
| 2019 | $-163 |
| 2018 | $-230 |
| 2017 | $-40 |
| 2016 | $-19 |
| Orchard Therapeutics PLC Sponsored ADR Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2023-09-30 | $-35 |
| 2023-06-30 | $-12 |
| 2023-03-31 | $-17 |
| 2022-12-31 | $-8 |
| 2022-09-30 | $-48 |
| 2022-06-30 | $-51 |
| 2022-03-31 | $-44 |
| 2021-12-31 | $-36 |
| 2021-09-30 | $-36 |
| 2021-06-30 | $-37 |
| 2021-03-31 | $-35 |
| 2020-12-31 | $-34 |
| 2020-09-30 | $-20 |
| 2020-06-30 | $-48 |
| 2020-03-31 | $-51 |
| 2019-12-31 | $-45 |
| 2019-09-30 | $-37 |
| 2019-06-30 | $-51 |
| 2019-03-31 | $-31 |
| 2018-12-31 | $-25 |
| 2018-09-30 | $-34 |
| 2018-06-30 | $-156 |
| 2018-03-31 | $-15 |
